ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-38A8577
Home | Market Reports | Health| Pharmacy
China Dipeptide Peptidase 4 DPP 4 Inhibitors Market Report Forecast 2021 2027
BUY CHAPTERS

Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Research Report 2025

Code: QYRE-Auto-38A8577
Report
August 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS

Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size

The global market for Dipeptide Peptidase 4 (DPP-4) Inhibitors was valued at US$ 9657 million in the year 2024 and is projected to reach a revised size of US$ 11300 million by 2031, growing at a CAGR of 2.3% during the forecast period.

Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dipeptide Peptidase 4 (DPP-4) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dipeptide Peptidase 4 (DPP-4) Inhibitors.
The Dipeptide Peptidase 4 (DPP-4) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dipeptide Peptidase 4 (DPP-4) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dipeptide Peptidase 4 (DPP-4) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Report

Report Metric Details
Report Name Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
Accounted market size in year US$ 9657 million
Forecasted market size in 2031 US$ 11300 million
CAGR 2.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Sitagliptin
  • Saxagliptin
  • Linagliptin
  • Alogliptin
  • Vildagliptin
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Eli Lilly, AstraZenica, Boehringer Ingelheim, Takeda Pharmaceutical Company, BMS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dipeptide Peptidase 4 (DPP-4) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Dipeptide Peptidase 4 (DPP-4) Inhibitors Market growing?

Ans: The Dipeptide Peptidase 4 (DPP-4) Inhibitors Market witnessing a CAGR of 2.3% during the forecast period 2025-2031.

What is the Dipeptide Peptidase 4 (DPP-4) Inhibitors Market size in 2031?

Ans: The Dipeptide Peptidase 4 (DPP-4) Inhibitors Market size in 2031 will be US$ 11300 million.

Who are the main players in the Dipeptide Peptidase 4 (DPP-4) Inhibitors Market report?

Ans: The main players in the Dipeptide Peptidase 4 (DPP-4) Inhibitors Market are Merck, Eli Lilly, AstraZenica, Boehringer Ingelheim, Takeda Pharmaceutical Company, BMS

What are the Application segmentation covered in the Dipeptide Peptidase 4 (DPP-4) Inhibitors Market report?

Ans: The Applications covered in the Dipeptide Peptidase 4 (DPP-4) Inhibitors Market report are Hospitals, Clinics

What are the Type segmentation covered in the Dipeptide Peptidase 4 (DPP-4) Inhibitors Market report?

Ans: The Types covered in the Dipeptide Peptidase 4 (DPP-4) Inhibitors Market report are Sitagliptin, Saxagliptin, Linagliptin, Alogliptin, Vildagliptin

1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Overview
1.1 Product Definition
1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors by Type
1.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Linagliptin
1.2.5 Alogliptin
1.2.6 Vildagliptin
1.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application
1.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue 2020-2031
1.4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales 2020-2031
1.4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competition by Manufacturers
2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Date of Enter into This Industry
2.8 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competitive Situation and Trends
2.8.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dipeptide Peptidase 4 (DPP-4) Inhibitors Players Market Share by Revenue
2.8.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Scenario by Region
3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region: 2020-2031
3.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region: 2020-2025
3.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region: 2026-2031
3.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2020-2031
3.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2020-2025
3.3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2026-2031
3.4 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.4.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2020-2031)
3.4.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2020-2031)
3.5.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2020-2031)
3.6.3 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2020-2031)
3.7.3 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2020-2031)
4.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2020-2025)
4.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2026-2031)
4.1.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2031)
4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2020-2031)
4.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2020-2025)
4.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2026-2031)
4.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2020-2031)
4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2020-2031)
5.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2020-2025)
5.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2026-2031)
5.1.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2020-2031)
5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2020-2031)
5.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2020-2025)
5.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2026-2031)
5.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2020-2031)
5.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 AstraZenica
6.3.1 AstraZenica Company Information
6.3.2 AstraZenica Description and Business Overview
6.3.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.3.5 AstraZenica Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Takeda Pharmaceutical Company
6.5.1 Takeda Pharmaceutical Company Company Information
6.5.2 Takeda Pharmaceutical Company Description and Business Overview
6.5.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.5.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.6 BMS
6.6.1 BMS Company Information
6.6.2 BMS Description and Business Overview
6.6.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
6.6.5 BMS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Chain Analysis
7.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Mode & Process Analysis
7.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales and Marketing
7.4.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Channels
7.4.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors
7.5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customer Analysis
8 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Dynamics
8.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Trends
8.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Drivers
8.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Challenges
8.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS
List of Tables
 Table 1. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Product Type & Application
 Table 12. Global Key Manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptide Peptidase 4 (DPP-4) Inhibitors as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2020-2025)
 Table 19. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2026-2031)
 Table 21. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2020-2025)
 Table 23. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2026-2031)
 Table 25. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) by Type (2020-2025)
 Table 51. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) by Type (2026-2031)
 Table 52. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2020-2025)
 Table 53. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2026-2031)
 Table 54. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2020-2025)
 Table 57. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2026-2031)
 Table 58. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) by Application (2020-2025)
 Table 61. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units) by Application (2026-2031)
 Table 62. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2020-2025)
 Table 63. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2026-2031)
 Table 64. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2020-2025)
 Table 67. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2026-2031)
 Table 68. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. AstraZenica Company Information
 Table 81. AstraZenica Description and Business Overview
 Table 82. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
 Table 84. AstraZenica Recent Developments/Updates
 Table 85. Boehringer Ingelheim Company Information
 Table 86. Boehringer Ingelheim Description and Business Overview
 Table 87. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
 Table 89. Boehringer Ingelheim Recent Developments/Updates
 Table 90. Takeda Pharmaceutical Company Company Information
 Table 91. Takeda Pharmaceutical Company Description and Business Overview
 Table 92. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
 Table 94. Takeda Pharmaceutical Company Recent Developments/Updates
 Table 95. BMS Company Information
 Table 96. BMS Description and Business Overview
 Table 97. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product
 Table 99. BMS Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors List
 Table 103. Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers List
 Table 104. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Trends
 Table 105. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Drivers
 Table 106. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Challenges
 Table 107. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dipeptide Peptidase 4 (DPP-4) Inhibitors
 Figure 2. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Type: 2024 & 2031
 Figure 4. Sitagliptin Product Picture
 Figure 5. Saxagliptin Product Picture
 Figure 6. Linagliptin Product Picture
 Figure 7. Alogliptin Product Picture
 Figure 8. Vildagliptin Product Picture
 Figure 9. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application: 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Clinics
 Figure 13. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (2020-2031) & (K Units)
 Figure 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Price (USD/Unit) & (2020-2031)
 Figure 17. Dipeptide Peptidase 4 (DPP-4) Inhibitors Report Years Considered
 Figure 18. Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Manufacturers in 2024
 Figure 19. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Dipeptide Peptidase 4 (DPP-4) Inhibitors Players: Market Share by Revenue in Dipeptide Peptidase 4 (DPP-4) Inhibitors in 2024
 Figure 21. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2031)
 Figure 24. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2031)
 Figure 28. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2020-2031)
 Figure 36. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Type (2020-2031)
 Figure 58. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors by Application (2020-2031)
 Figure 61. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2020-2031)
 Figure 62. Dipeptide Peptidase 4 (DPP-4) Inhibitors Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions